These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1726008)

  • 41. Endothelial dysfunction, hypertension and atherosclerosis. A review of the effects of lacidipine.
    Haller H; Cosentino F; Lüscher TF
    Drugs R D; 2002; 3(5):311-23. PubMed ID: 12455152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large artery dilation produced by converting enzyme inhibition in hypertension: therapeutic aspects.
    Safar ME; Asmar RG; Benetos A
    Am J Med; 1992 Apr; 92(4B):47S-53S. PubMed ID: 1580280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure.
    Anacak GY; Ustünes L; Dilsiz OY; Ergul A
    Vascul Pharmacol; 2010; 53(5-6):193-9. PubMed ID: 20709189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulsed Doppler evaluation of diameter, blood velocity and blood flow of common carotid artery in sustained essential hypertension.
    Bouthier J; Benetos A; Simon A; Levenson J; Safar M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S99-104. PubMed ID: 2409379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Involvement of calcium channels in the pathogenesis of hypertension].
    Murakami M; Iijima T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():152-5. PubMed ID: 15171360
    [No Abstract]   [Full Text] [Related]  

  • 46. [Calcium channel blockers and cerebral circulation].
    Uematsu D; Fukuuchi Y
    Nihon Rinsho; 1989 Aug; 47(8):1770-5. PubMed ID: 2585739
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effects of lacidipine, a new dihydropyridipine derivative, on various cerebral ischemia models].
    Funato H; Katsuki Y; Yano T; Kawano H; Akada Y; Sato M; Uemura A
    Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):243-57. PubMed ID: 8974085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic progressive changes in brachial and carotid artery circulations under the combined effects of aging and hypertension.
    Nguyen PC; Levenson J; Simon A
    J Hypertens; 1990 May; 8(5):449-55. PubMed ID: 2163420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium antagonists in the treatment of arterial hypertension.
    Parati G; Mancia G
    Am Heart J; 1993 Feb; 125(2 Pt 2):642-8. PubMed ID: 8430611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Angiographic studies on the effects of a novel calcium antagonist AE0047 on cerebral arteries in dogs, with special reference to the preventive effects of AE0047 on cerebral vasoconstriction induced by endothelin].
    Kido H; Uchida Y; Nakamura F; Sugimoto T
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):177-84. PubMed ID: 2196210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carotid artery stiffness with applications to cardiovascular pharmacology.
    Safar ME
    Gen Pharmacol; 1996 Dec; 27(8):1293-302. PubMed ID: 9304398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Different sensitivities of cerebral arterial systems to noradrenaline].
    Mirzoian RS
    Biull Eksp Biol Med; 1976 Jan; 81(1):47-9. PubMed ID: 1247678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical application of calcium antagonists in the treatment of hypertension].
    Takeda K; Nakagawa M
    Nihon Rinsho; 1989 Sep; 47(9):2052-7. PubMed ID: 2593278
    [No Abstract]   [Full Text] [Related]  

  • 54. Cerebral blood flow and calcium antagonists in hypertension.
    Conen D; Bertel O; Dubach UC
    J Hypertens Suppl; 1987 Dec; 5(4):S75-80. PubMed ID: 3326921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The common carotid circulation in patients with essential hypertension.
    Safar ME; Laurent S; Benetos A; London GM
    Stroke; 1988 Oct; 19(10):1198-202. PubMed ID: 3176079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of lacidipine on fatty and proliferative lesions induced in hypercholesterolaemic rabbits.
    Soma MR; Donetti E; Seregni R; Barberi L; Fumagalli R; Paoletti R; Catapano AL
    Br J Pharmacol; 1996 May; 118(2):215-9. PubMed ID: 8735617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of blood pressure lowering on coronary vasodilator reserve in arterial hypertension.
    Gistri R; Ebert AG; Palombo C; Marabotti C; Choudhury L; Camici PG
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):169-71. PubMed ID: 8086329
    [No Abstract]   [Full Text] [Related]  

  • 58. [Lacidipine: a new third generation calcium channel blocker].
    Vertkin AL; Topolianskiĭ AV
    Kardiologiia; 2002; 42(2):100-3. PubMed ID: 14587530
    [No Abstract]   [Full Text] [Related]  

  • 59. Vasodilatation of small and large arteries in hypertension.
    Levenson JA; Simon AC; Safar ME
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S115-20. PubMed ID: 2409359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Possibility of the outpatient use of lacidipine in elderly patients with hypertension].
    Alekseeva NP; Runikhina NK; Larin VG; Krasina GF
    Kardiologiia; 2002; 42(1):67-9. PubMed ID: 12494227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.